Healthcare and Life Science
Arecor presents positive data from phase I clinical trial of ultra-concentrated ultra-rapid acting insulin AT278
- AT278 delivers significantly accelerated early PK/PD profile compared with NovoRapid® in people with Type 2 Diabetes and high BMI - Results confirm previous findings in people with Type 1 diabetes and show that AT278 can maintain the faster action p...
Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors
Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones London, UK, 11 Sep 2024: Closed Loop Medicine Ltd., a leading TechBio company leveraging AI, machine learning, and personalized dosing to enhance dr...
Cellular Origins and 3P innovation collaborate to accelerate industrialisation of CGT manufacturing
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation ...
Enterprise Therapeutics appoints Annabella Amatulli as Head of Regulatory Affairs
Appointment brings extensive regulatory experience as lead asset ETD001 progresses through Phase 2 clinical trial for treatment of cystic fibrosis Brighton, UK, 11 September 2024: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and devel...
Engagement and motivation at work: what's the difference?
At work, you’ve probably heard people throwing around the terms “motivation” and “engagement” like they’re the same thing. Spoiler alert: They’re not. While both are crucial for driving employee performance and satisfaction, they represent distinct aspects of how we experience the workp...
Health Innovation East and 42T webinar to help power Net Zero NHS
Health Innovation East, the innovation arm of the NHS in the East of England and 42 Technology (42T), a product design and innovation consultancy, are co-hosting a free webinar aimed at helping the NHS achieve its ambitious net zero goals. ...
Team’s hip replacement surgery invention is set to be world first
Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge. ...
Common diabetes drug slows growth of normal cells carrying cancer mutation
A common diabetes medication, metformin, slows the growth of precancerous cells in the oesophagus while some metabolic conditions accelerate it, suggests a new study. ...
PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Manageme...
o2h technology announces the launch of the third edition of the Tech Kickstarter Competition
Cambridge, UK: o2h technology, a business vertical of the o2h group, is thrilled to announce the launch of the third edition of its Tech Kickstarter Competition. This initiative is designed to support innovative seed and early stage companies by helping them meet their MVP, we...